Albion Financial Group’s Bio-Techne TECH Stock Holding History

Albion Financial Group’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-18	Closed	-$941	–	743
2026 Q1	$941	Buy	+18	New	+$1.08K	﹤0.01%	645

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Albion Financial Group's TECH Position: Q2 2026 in Review

Albion Financial Group sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 18 shares — an estimated $941 sold.

Albion Financial Group first reported a position in TECH in Q1 2026 and held it in 1 quarter. The position peaked at $941 in Q1 2026. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Albion Financial Group reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
Albion Financial Group sold 18 Bio-Techne shares in Q2 2026, an estimated $941.
Albion Financial Group first reported a position in Bio-Techne in Q1 2026 and held it in 1 quarter.
Albion Financial Group's Bio-Techne position peaked at $941 in Q1 2026.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Albion Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.